Oliver von Ahsen

Years Active: 2019-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Khan, Sami S Khaznadar, Johannes Routila, Sami Ventelä, Elke Schmid, Bastian Gebhart, Eva T Becker, Helge G Roider, Merja Perala, Arndt A Schmitz, Thomas Krahn, Oliver von Ahsen
Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients. Head & neck 42 (4) (2020)
Stefanie Hammer, Urs B Hagemann, Sabine Zitzmann-Kolbe, Aasmund Larsen, Christine Ellingsen, Solene Geraudie, Derek Grant, Baard Indrevoll, Roger Smeets, Oliver von Ahsen, Alexander Kristian, Pascale Lejeune, Hartwig Hennekes, Jenny Karlsson, Roger M Bjerke, Olav B Ryan, Alan S Cuthbertson, Dominik Mumberg
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (8) (2019)

Oliver von Ahsen.css-eqlu8i{font-size:small;padding-left:4px;}